Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Cited In for PubMed (Select 19132446)

1.

Sentinel lymph node biopsy in head and neck melanoma*.

Giudice G, Leuzzi S, Robusto F, Ronghi V, Nacchiero E, Giardinelli G, Di Gioia G, Ragusa L, Pascone M.

G Chir. 2014 May-Jun;35(5-6):149-55.

2.

Tumors induce coordinate growth of artery, vein, and lymphatic vessel triads.

Ruddell A, Croft A, Kelly-Spratt K, Furuya M, Kemp CJ.

BMC Cancer. 2014 May 21;14:354. doi: 10.1186/1471-2407-14-354.

3.

Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas.

Chu VH, Tetzlaff MT, Torres-Cabala CA, Prieto VG, Bassett R Jr, Gershenwald JE, McLemore MS, Ivan D, Wang WL, Ross MI, Curry JL.

Biomed Res Int. 2013;2013:898719. doi: 10.1155/2013/898719. Epub 2013 Dec 3.

4.

SLN melanoma micrometastasis predictivity of nodal status: a long term retrospective study.

Migliano E, Bellei B, Govoni FA, Paolino G, Catricalà C, Bucher S, Donati P.

J Exp Clin Cancer Res. 2013 Aug 1;32:47. doi: 10.1186/1756-9966-32-47.

5.

Sentinel lymph node biopsy in melanoma: our 8-year clinical experience in a single French institute (2002-2009).

Biver-Dalle C, Puzenat E, Puyraveau M, Delroeux D, Boulahdour H, Sheppard F, Pelletier F, Humbert P, Aubin F.

BMC Dermatol. 2012 Dec 10;12:21. doi: 10.1186/1471-5945-12-21.

6.

A neoadjuvant biochemotherapy approach to stage III melanoma: analysis of surgical outcomes.

Kounalakis N, Gao D, Gonzalez R, Becker M, Lewis K, Poust J, Pearlman N, Robinson W, McCarter M.

Immunotherapy. 2012 Jul;4(7):679-86. doi: 10.2217/imt.12.62.

7.

Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node.

Ma MW, Medicherla RC, Qian M, Vega-Saenz de Miera E, Friedman EB, Berman RS, Shapiro RL, Pavlick AC, Ott PA, Bhardwaj N, Shao Y, Osman I, Darvishian F.

Mod Pathol. 2012 Jul;25(7):1000-10. doi: 10.1038/modpathol.2012.43. Epub 2012 Mar 16.

8.

First Experiences with Navigated Radio-Guided Surgery Using Freehand SPECT.

Rieger A, Saeckl J, Belloni B, Hein R, Okur A, Scheidhauer K, Wendler T, Traub J, Friess H, Martignoni ME.

Case Rep Oncol. 2011 May;4(2):420-5. doi: 10.1159/000330273. Epub 2011 Aug 30.

9.

Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database.

White RL Jr, Ayers GD, Stell VH, Ding S, Gershenwald JE, Salo JC, Pockaj BA, Essner R, Faries M, Charney KJ, Avisar E, Hauschild A, Egberts F, Averbook BJ, Garberoglio CA, Vetto JT, Ross MI, Chu D, Trisal V, Hoekstra H, Whitman E, Wanebo HJ, Debonis D, Vezeridis M, Chevinsky A, Kashani-Sabet M, Shyr Y, Berry L, Zhao Z, Soong SJ, Leong SP; Sentinel Lymph Node Working Group.

Ann Surg Oncol. 2011 Dec;18(13):3593-600. doi: 10.1245/s10434-011-1826-9. Epub 2011 Jun 7.

10.

Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.

Rutkowski P, Nowecki ZI, van Akkooi AC, Kulik J, Wanda M, Siedlecki JA, Eggermont AM, Ruka W.

Ann Surg Oncol. 2010 Dec;17(12):3314-23. doi: 10.1245/s10434-010-1142-9. Epub 2010 Jul 7.

11.

Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.

Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Ding S, Byrd DR, Cascinelli N, Cochran AJ, Coit DG, Eggermont AM, Johnson T, Kirkwood JM, Leong SP, McMasters KM, Mihm MC Jr, Morton DL, Ross MI, Sondak VK.

J Clin Oncol. 2010 May 10;28(14):2452-9. doi: 10.1200/JCO.2009.27.1627. Epub 2010 Apr 5.

12.

Who is to blame for false-negative sentinel node biopsies in melanoma?

Sondak VK, Zager JS.

Ann Surg Oncol. 2010 Mar;17(3):670-3. doi: 10.1245/s10434-009-0857-y. No abstract available.

13.

False-negative sentinel node biopsy.

Nieweg OE.

Ann Surg Oncol. 2009 Aug;16(8):2089-91. doi: 10.1245/s10434-009-0540-3. Epub 2009 Jun 12. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk